A Placebo-Controlled Study to Evaluate the Effect of a Single Dose of CVN058-103 on Mismatch Negativity in Subjects with Stable Schizophrenia
CVN058 Effect on Mismatch Negativity in Schizophrenics
Sponsor: Cerevance
Enrolling: Male and Female Patients
IRB Number: 7677
U.S. Govt. ID: NCT03669250
Contact: Marlene Carlson, MPH: 646-774-8436 / mc157@columbia.edu
Additional Study Information: The purpose of this study is to determine whether the brain wave patterns are improved after administration of CVN058 compared to placebo in subjects with schizophrenia. The study uses electroencephalography (EEG) to measure naturally occurring brain waves as you listen to recorded sounds.
This study is closed
Joshua Kantrowitz, MD
Do You Qualify?
Do you have schizophrenia? Yes No
Are you between the ages of 18-50? Yes No
Are you / have you been on Clozapine? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Marlene Carlson, MPH